Home Cart Sign in  
Chemical Structure| 301357-74-4 Chemical Structure| 301357-74-4

Structure of HIV-IN-6
CAS No.: 301357-74-4

Chemical Structure| 301357-74-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

HIV-IN-6 is an inhibitor targeting HIV-1 replication by interacting with Src family kinases involved in Nef protein interactions, showing potential to inhibit viral transmission, applicable in anti-HIV disease research.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of HIV-IN-6

CAS No. :301357-74-4
Formula : C20H16N4O3S
M.W : 392.43
SMILES Code : O=S(C1=CC=CC=C1)(NC2=NC3=CC=CC=C3N=C2NC4=CC(O)=CC=C4)=O
MDL No. :N/A
InChI Key :BNHZFBKIEIPSHA-UHFFFAOYSA-N
Pubchem ID :2309588

Safety of HIV-IN-6

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Related Pathways of HIV-IN-6

RTK

Isoform Comparison

Biological Activity

Description
HIV-IN-6 targets Src family kinases (SFK) that interact with the Nef protein of HIV-Ⅰ, inhibiting viral replication[1].

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.55mL

0.51mL

0.25mL

12.74mL

2.55mL

1.27mL

25.48mL

5.10mL

2.55mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories